Den Europæiske Union - dansk - EMA (European Medicines Agency)

roche registration gmbh  - pralsetinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

zoetis belgium sa - toceranib - antineoplastiske midler - hunde - behandling af ikke-resekterbare patnaik grade ii (mellemklasse) eller -iii (højkvalitets), tilbagevendende, kutane mastcelletumorer hos hunde.